Benign or malignant pulmonary lesions
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a peripheral pulmonary nodule or mass who need to undergo diagnostic bronchoscopy. 2. 20 years and above 3. Informed consent
Exclusion criteria
Exclusion criteria: 1. Serious concomitant medical illness 2. Obvious central pulmonary lesion 3. Diffuse pulmonary lesions 4. Re-examination due to prior failure in this trial 5. Obvious bleeding tendency 6. Pregnancy 7. Other clinical difficulties in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic yield | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Frequency of adverse effects 2. Level of bronchus reached 3. Visibility on EBUS 4. Direct visibility of lesions with bronchoscope 5. Optimal number of biopsies | — |
Countries
Japan
Contacts
Nagoya Medical Center Department of Respiratory Medicine